Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

CTO: in Radial Access with Similar Results to Femoral

Courtesy of Dr. Carlos Fava.

One of the characteristics of chronic total occlusion (CTO) is the use of two access routes: femoral and radial. The radial approach is safer, but it has not been thoroughly analyzed in this type of PCI.

Successful CTO Reduces Local and Remote Residual IschemiaThe study looked at 3709 patients undergoing left main percutaneous coronary intervention (PCI) for CTO. Only 2157 patients were accessed via femoral approach (58.1%), 728 via radial approach (19.6%), and 824 via both femoral and radial approach (22.2%). The use of radial approach increased over time.

 

Mean age was 65, and most patients were men. Those undergoing radial access or femoral and radial access PCI were younger, had more acute coronary syndrome, and less risk factors, peripheral coronary heart disease, or prior revascularization procedures.



Read also: Asymptomatic Coronary Artery Disease, Silent Ischemia: A Cardiologist’s Headache.


J-CTO score (Multicenter CTO Registry in Japan) was lower in radial access patients (2.1±1.4 vs. 2.6±1.3 vs. 2.5±1.3; p < 0.001).

 

Antegrade dissection re-entry was less used in radial access patients, while retrograde techniques were higher.

 

Technical and procedural success was similar for the three strategies.


Read also: Abluminal Sirolimus and luminal CD34 antibody layer: Is COMBO the Future of Stents?


As regards in-hospital complications, there were no differences in mortality or MACE, but there was a higher rate of bleeding in the femoral approach group.

 

Conclusion

The use of radial access is no the rise when it comes to PCI for CTO, seeing as it is associated with less major bleeding, compared with the use of the femoral approach alone.

 

Courtesy of Dr. Carlos Fava.

 

Título original: Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach. Insights From an International Chronic Total Occlusion Registry.

Reference: Peter Tajti, et al J Am Coll Cardiol Intv 2019;12:346–58.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...